Independent Advisor Alliance Takes $577,000 Position in Phibro Animal Health Corporation (NASDAQ:PAHC)

Key Points

• Independent Advisor Alliance has acquired a new stake in Phibro Animal Health Corporation, purchasing 26,995 shares valued at approximately $577,000 during the first quarter of the year.
• Several hedge funds have recently bought shares of Phibro Animal Health, increasing institutional ownership to 99.34% of the company’s stock.
• Equities analysts have set various price targets for Phibro Animal Health, with the consensus price target currently at $24.40 and a mix of ratings ranging from sell to buy.

Independent Advisor Alliance purchased a new stake in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 26,995 shares of the company's stock, valued at approximately $577,000. Independent Advisor Alliance owned 0.07% of Phibro Animal Health as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of PAHC. Point72 Asia Singapore Pte. Ltd. purchased a new position in Phibro Animal Health during the fourth quarter valued at approximately $29,000. National Bank of Canada FI purchased a new position in Phibro Animal Health during the first quarter valued at approximately $30,000. Lazard Asset Management LLC grew its stake in Phibro Animal Health by 2,739.7% during the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock valued at $34,000 after acquiring an additional 1,589 shares in the last quarter. Aquatic Capital Management LLC purchased a new position in Phibro Animal Health in the 4th quarter worth approximately $69,000. Finally, Virtus Fund Advisers LLC purchased a new position in Phibro Animal Health in the 4th quarter worth approximately $69,000. Hedge funds and other institutional investors own 99.34% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Morgan Stanley set a $26.00 price target on shares of Phibro Animal Health and gave the stock an "equal weight" rating in a research note on Wednesday, June 25th. BNP Paribas raised shares of Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. BNP Paribas Exane raised shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target for the company in a research note on Monday, June 16th. Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Finally, JPMorgan Chase & Co. raised shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and boosted their price target for the stock from $25.00 to $35.00 in a research note on Monday, July 7th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $24.40.

Phibro Animal Health Price Performance

Shares of Phibro Animal Health stock opened at $30.57 on Friday. Phibro Animal Health Corporation has a 52-week low of $16.16 and a 52-week high of $31.80. The stock has a market capitalization of $1.24 billion, a price-to-earnings ratio of 39.19, a price-to-earnings-growth ratio of 0.52 and a beta of 0.80. The company has a fifty day moving average of $27.44 and a 200-day moving average of $23.72. The company has a debt-to-equity ratio of 2.67, a quick ratio of 1.23 and a current ratio of 2.91.

Phibro Animal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, September 3rd. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.6%. Phibro Animal Health's dividend payout ratio is 61.54%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.